TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 17.74

Change

+0.28 (+1.60)%

Market Cap

N/A

Volume

4.87M

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+3.34 (+1.74%)

USD 89.02B
HLN Haleon plc

N/A

USD 48.04B
TAK Takeda Pharmaceutical Co Ltd A..

+0.07 (+0.48%)

USD 47.42B
RDY Dr. Reddy’s Laboratories Ltd..

+0.42 (+0.53%)

USD 13.05B
CTLT Catalent Inc

+0.43 (+0.72%)

USD 10.91B
ELAN Elanco Animal Health

+0.07 (+0.51%)

USD 6.96B
BHC Bausch Health Companies Inc

+0.08 (+1.00%)

USD 2.98B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.01 (+0.12%)

USD 2.58B
CPHI China Pharma Holdings Inc

+0.03 (+12.55%)

USD 3.66M
YCBD cbdMD Inc

N/A

USD 1.73M

ETFs Containing TEVA

ISRA VanEck Israel ETF 10.18 % 0.60 %

+0.71 (+1.06%)

USD 0.07B
FLWR:SW 5.80 % 0.00 %

N/A

N/A
ISRZF iShares II Public Limited.. 5.39 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 4.81 % 0.00 %

+2.41 (+1.06%)

N/A
ISRWF iShares II Public Limited.. 4.75 % 0.00 %

N/A

N/A
ISRHF iShares V Public Limited .. 4.35 % 0.00 %

N/A

N/A
ISRUF iShares V Public Limited .. 4.35 % 0.00 %

N/A

N/A
IDVO Amplify International Enh.. 3.08 % 0.00 %

+0.33 (+1.06%)

USD 0.10B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

+1.39 (+1.06%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRPF iShares Public Limited Co.. 0.00 % 0.00 %

N/A

USD 2.22B
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.42 (+1.06%)

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 69.92% 93% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.92% 93% A 98% N/A
Trailing 12 Months  
Capital Gain 73.58% 87% B+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.58% 87% B+ 95% A
Trailing 5 Years  
Capital Gain 156.36% 92% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 156.36% 93% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 10.27% 75% C 69% C-
Dividend Return 10.27% 63% D 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.33% 56% F 27% F
Risk Adjusted Return 28.28% 56% F 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector